Enanta Pharmaceuticals Inc (ENTA)
9.31
+0.23
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
9.30
-0.01
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Revenue (Quarterly): 17.97M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.97M |
| March 31, 2024 | 17.05M |
| December 31, 2023 | 18.00M |
| September 30, 2023 | 18.93M |
| June 30, 2023 | 18.89M |
| March 31, 2023 | 17.80M |
| December 31, 2022 | 23.58M |
| September 30, 2022 | 20.32M |
| June 30, 2022 | 19.48M |
| March 31, 2022 | 18.72M |
| December 31, 2021 | 27.65M |
| September 30, 2021 | 23.58M |
| June 30, 2021 | 21.62M |
| March 31, 2021 | 20.13M |
| December 31, 2020 | 31.74M |
| September 30, 2020 | 23.63M |
| June 30, 2020 | 18.65M |
| March 31, 2020 | 27.62M |
| December 31, 2019 | 52.57M |
| September 30, 2019 | 51.31M |
| June 30, 2019 | 44.37M |
| March 31, 2019 | 39.63M |
| December 31, 2018 | 69.89M |
| September 30, 2018 | 67.20M |
| June 30, 2018 | 57.26M |
| Date | Value |
|---|---|
| March 31, 2018 | 44.05M |
| December 31, 2017 | 38.11M |
| September 30, 2017 | 75.93M |
| June 30, 2017 | 7.511M |
| March 31, 2017 | 8.959M |
| December 31, 2016 | 10.42M |
| September 30, 2016 | 12.84M |
| June 30, 2016 | 13.98M |
| March 31, 2016 | 13.00M |
| December 31, 2015 | 48.44M |
| September 30, 2015 | 14.42M |
| June 30, 2015 | 11.60M |
| March 31, 2015 | 57.37M |
| December 31, 2014 | 77.50M |
| September 30, 2014 | 2.637M |
| June 30, 2014 | 42.05M |
| March 31, 2014 | 2.16M |
| December 31, 2013 | 0.893M |
| September 30, 2013 | 1.349M |
| June 30, 2013 | 1.649M |
| March 31, 2013 | 1.196M |
| December 31, 2012 | 27.86M |
| September 30, 2012 | 1.858M |
| June 30, 2012 | 2.542M |
| March 31, 2012 | 36.56M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
17.05M
Minimum
Mar 2024
52.57M
Maximum
Dec 2019
23.05M
Average
20.13M
Median
Mar 2021
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.66M |
| Total Expenses (Quarterly) | 42.16M |
| EPS Diluted (Quarterly) | -1.07 |
| Enterprise Value | -32.82M |
| Profit Margin (Quarterly) | -126.1% |
| Earnings Yield | -58.54% |
| Normalized Earnings Yield | -58.54 |